Component: (Network and Table)
Network
00100 - Statement - CONSOLIDATED BALANCE SHEETS
(http://www.depomed.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001005201 (http://www.sec.gov/CIK)
CONSOLIDATED BALANCE SHEETSPeriod [Axis]
2016-12-31
2015-12-31
CONSOLIDATED BALANCE SHEETS
 
 
ASSETS
 
 
Current assets:
 
 
Cash and cash equivalents
117,709,000  
101,084,000  
Short-term investments
59,711,000  
108,684,000  
Accounts receivable, net
102,056,000  
71,125,000  
Receivables from collaborative partners
533,000  
562,000  
Inventories
13,033,000  
10,494,000  
Income taxes receivable
 
6,358,000  
Prepaid and other current assets
13,162,000  
10,665,000  
Total current assets
306,204,000  
 
308,972,000  
 
Property and equipment, net
15,526,000  
14,794,000  
Intangible assets, net
902,149,000  
1,008,994,000  
Deferred tax assets
 
22,995,000  
Other assets
1,458,000  
1,494,000  
Total Assets
1,225,337,000  
 
1,357,249,000  
 
LIABILITIES AND SHAREHOLDERS' EQUITY
 
 
Current liabilities:
 
 
Accounts payable
14,855,000  
12,805,000  
Accrued rebates, returns and discounts
131,536,000  
121,058,000  
Accrued liabilities
59,398,000  
62,931,000  
Income taxes payable
59,000  
 
Contingent consideration liability, current portion
4,578,000  
3,318,000  
Interest payable
15,924,000  
18,672,000  
Other current liabilities
892,000  
848,000  
Total current liabilities
227,242,000  
 
219,632,000  
 
Contingent consideration liability, long-term portion
10,247,000  
11,653,000  
Senior Notes
466,051,000  
563,012,000  
Convertible Notes
252,725,000  
237,313,000  
Other long-term liabilities
18,284,000  
10,584,000  
Commitments
xsi:nil  
xsi:nil  
Shareholders' equity:
 
 
Preferred stock, no par value, 5,000,000 shares authorized; Series A convertible preferred stock, 25,000 shares designated and zero shares outstanding at December 31, 2016 and December 31, 2015
xsi:nil  
xsi:nil  
Common stock, no par value, 200,000,000 shares authorized; 61,996,188 and 60,787,309 shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively
291,634,000  
264,511,000  
Additional paid-in capital
75,917,000  
78,622,000  
Accumulated deficit
(116,744,000) 
(28,024,000) 
Accumulated other comprehensive loss, net of tax
(19,000) 
(54,000) 
Total shareholders' equity
250,788,000  
 
315,055,000  
 
Total liabilities and shareholders' equity
1,225,337,000  
 
1,357,249,000